Gene · 5891
Papers1,940
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,940
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanistic insights into BDE-153-induced idiopathic pulmonary fibrosis through network toxicology, machine learning, and cellular validation. | Food Chem Toxicol | 2026 | 42167473 | PubTator, text mining | PubMed |
| Identification of diagnostic senescence-associated marker genes in asthma based on machine learning and experimental validation. | Biochem Biophys Res Commun | 2026 | 42161063 | PubTator, text mining | PubMed |
| An integrated single-cell and spatial proteotranscriptomics atlas of fibroblast-driven immunoregulation within the human adult oral cavity. | Cell Press Blue | 2026 | 42147490 | PubTator, text mining | PubMed |
| Microglia-driven neuroinflammation in ischemic stroke: insights from high altitude hypoxia. | Neuroscience | 2026 | 42103076 | PubTator, text mining | PubMed |
Gastrointestinal symptoms in Parkinson's disease treated in a controlled trial using traditional Chinese medicine (Jia-Wei-Ji-Chuan-Jian decoction) with network pharmacology analysis of active agents and mechanism of action. | Int J Clin Pharmacol Ther | 2026 | 42084228 | PubTator, text mining | PubMed |
| Suboptimal Responses to Anti-VEGF in Retinal Neurovascular Diseases: Linking Aging and Alternative Angioinflammatory Pathways. | Invest Ophthalmol Vis Sci | 2026 | 42080790 | PubTator, text mining | PubMed |
| Ligation of TLR2, but not of TLR4 or other Toll-like receptors, induces neutrophil extracellular trap formation in humans. | J Immunol | 2026 | 42030533 | PubTator, text mining | PubMed |
| Unveiling the mechanism of action of Cymarin in combating breast cancer: An integrated computational analysis. | J Mol Graph Model | 2026 | 42026435 | PubTator, text mining | PubMed |
| The Diagnostic Promise of Serum S100B Protein in Pregnancy-Related Hypertension: A Narrative Review. | Health Sci Rep | 2026 | 41948640 | PubTator, text mining | PubMed |
| Microglial activation in diabetic neuropathic pain: Molecular trigger mechanisms, neuroimmune crosstalk, and emerging therapeutic targets. | Neuropeptides | 2026 | 41946011 | PubTator, text mining | PubMed |
| Programmed cell death: a promising management for Alzheimer's disease. | Apoptosis | 2026 | 41904723 | PubTator, text mining | PubMed |
| Network Pharmacology and Transcriptome Analysis Reveal Potential Cardiometabolic Targets of Polygonum cuspidatum. | Biomedicines | 2026 | 41898163 | PubTator, text mining | PubMed |
| S100A4: A calcium-binding protein at the crossroads of cancer, fibrosis, and antiviral immunity. | Biochem Biophys Res Commun | 2026 | 41875701 | PubTator, text mining | PubMed |
| Circulating cytokines mediate the risk of COPD: A mediation analysis based on 473 gut microbiota and 91 circulating cytokines. | Medicine (Baltimore) | 2026 | 41861166 | PubTator, text mining | PubMed |
| Lactate Metabolism-Immune Regulation-Related Gene Signature in Lower-Grade Gliomas: Prognostic Model Development and Immune Characterization. | FASEB J | 2026 | 41849028 | PubTator, text mining | PubMed |
| Synergistic Potential of Linagliptin and Resveratrol in Mitigating Type-II Diabetes-Induced Nephropathy: A Comprehensive Review. | Curr Diabetes Rev | 2026 | 41830569 | PubTator, text mining | PubMed |
| Berberine Ameliorates Diabetic Kidney Disease by Modulating Macrophage Polarization via Inhibiting IL-17A Signaling. | J Inflamm Res | 2026 | 41809762 | PubTator, text mining | PubMed |
| Rethinking network analysis in ethnopharmacology: a multi-omics and AI roadmap to overcome conceptual and methodological biases. | Front Pharmacol | 2026 | 41800093 | PubTator, text mining | PubMed |
| Neoadjuvant chemotherapy-induced immune remodeling in ovarian cancer: implications for TIL dynamics and combination immunotherapy. | Front Immunol | 2026 | 41798957 | PubTator, text mining | PubMed |
| Folinic Acid Improves Healing of Diabetic Foot Ulcers. | Wound Repair Regen | 2026 | 41795141 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5891/papers?page=2